119 related articles for article (PubMed ID: 10331509)
1. Activation of coagulation factor VII by tissue-type plasminogen activator.
Tsujioka H; Suehiro A; Kakishita E
Am J Hematol; 1999 May; 61(1):34-9. PubMed ID: 10331509
[TBL] [Abstract][Full Text] [Related]
2. The FVII activating protease cleaves single-chain plasminogen activators.
Römisch J; Vermöhlen S; Feussner A; Stöhr H
Haemostasis; 1999; 29(5):292-9. PubMed ID: 10754382
[TBL] [Abstract][Full Text] [Related]
3. [Effect of thrombolytic agents on platelets and blood coagulation system].
Suehiro A
Rinsho Byori; 1997 Oct; 45(10):951-6. PubMed ID: 9369072
[TBL] [Abstract][Full Text] [Related]
4. Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men.
Tholstrup T; Miller GJ; Bysted A; Sandström B
Am J Clin Nutr; 2003 May; 77(5):1125-32. PubMed ID: 12716662
[TBL] [Abstract][Full Text] [Related]
5. Influence of warfarin therapy on activated factor VII clotting activity.
Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method.
Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ
Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565
[TBL] [Abstract][Full Text] [Related]
7. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.
Toso R; Pinotti M; High KA; Pollak ES; Bernardi F
Biochem J; 2002 Apr; 363(Pt 2):411-6. PubMed ID: 11931672
[TBL] [Abstract][Full Text] [Related]
8. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
[TBL] [Abstract][Full Text] [Related]
9. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.
Morrissey JH; Macik BG; Neuenschwander PF; Comp PC
Blood; 1993 Feb; 81(3):734-44. PubMed ID: 8427965
[TBL] [Abstract][Full Text] [Related]
11. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven).
Johannessen M; Nielsen G; Nordfang O
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S159-64. PubMed ID: 10850583
[TBL] [Abstract][Full Text] [Related]
13. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
[TBL] [Abstract][Full Text] [Related]
14. Factor VII and activated-factor-VII content of prothrombin complex concentrates. The PCC Study Group.
Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
Vox Sang; 1997; 73(3):155-61. PubMed ID: 9358617
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
16. Consumption of plasma factor VII in a rabbit model of non-overt disseminated intravascular coagulation.
Clarke BJ; Sridhara S; Woskowska Z; Blajchman MA
Thromb Res; 2002 Dec; 108(5-6):329-34. PubMed ID: 12676194
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
[TBL] [Abstract][Full Text] [Related]
18. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
[TBL] [Abstract][Full Text] [Related]
19. Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin.
Smith SA; Comp PC; Morrissey JH
J Thromb Haemost; 2006 Jul; 4(7):1553-8. PubMed ID: 16839353
[TBL] [Abstract][Full Text] [Related]
20. Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.
Kario K; Matsuo T; Kobayashi H; Matsuo M; Sakata T; Miyata T
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1114-20. PubMed ID: 7627704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
